Novartis' threat that it would not introduce new medicines in India after the verdict is hollow, says Anand Grover.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances